Atlas Trials

Clinico-immunological Characterization and Immune Tolerance Breakdown in CV2-autoimmunity

Clinical trial NCT06620913 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06620913
Sponsor
Hospices Civils de Lyon
Status
ACTIVE_NOT_RECRUITING
Study type
OBSERVATIONAL
CV2 Autoimmunity
Start date
2024-05-01
Primary completion
2024-09-01
Enrollment
232

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.